Salmeterol Market - Forecast 2022-2027
Salmeterol Market Overview The Salmeterol Market size is estimated to reach $615 million by 2027. Furthermore, it is poised to grow at a CAGR of 3.82% over the forecast period of 2022-2027. Salmeterol is an adrenergic agonist receptor, which is preferably given for the treatment of bronchitis, asthma, and chronic obstructive pulmonary disease. Adrenoreceptor agonist is a drug that stimulates a response from the adrenergic receptors. The five main plausible adrenergic receptors are α1, α2, β1, β2, and β3. Additionally, the combination of fluticasone propionate and salmeterol has been a preferred combination by a variety of drug majors, moreover, the combination helps in reducing the shortness of breath, coughing symptoms, chest tightness, and various others. Another salt, commonly known as beclometasone dipropionate is prescribed by doctors to treat cough, chest tightness, and others for treating asthma in children older than 5 or more years. Moreover, Adenylyl cyclase (AC) is a key si...